Zobrazeno 1 - 10
of 249
pro vyhledávání: '"D. Santarsiero"'
Autor:
Saad Alqarni, Laura Cooper, Jazmin Galvan Achi, Ryan Bott, Veeresh Kumar Sali, Andrew Brown, Bernard D. Santarsiero, Aleksej Krunic, Balaji Manicassamy, Norton P. Peet, Pin Zhang, Gregory R. J. Thatcher, Irina N. Gaisina, Lijun Rong, Terry W. Moore
Publikováno v:
Journal of Medicinal Chemistry. 65:14104-14120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2419fd8cb167e8defe6024cc591faf50
https://doi.org/10.1021/acs.jmedchem.2c01329
https://doi.org/10.1021/acs.jmedchem.2c01329
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sherrie L. Heinz-Kunert, Ashma Pandya, Viet Thuc Dang, Phuong Nguyen Tran, Sabari Ghosh, Dan McElheny, Bernard D. Santarsiero, Zhong Ren, Andy I. Nguyen
Publikováno v:
Journal of the American Chemical Society. 144:7001-7009
The evolution of proteins from simpler, self-assembled peptides provides a powerful blueprint for the design of complex synthetic materials. Previously, peptide-metal frameworks using short sequences (≤3 residues) have shown great promise as proteo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef6c082464b0da5cbc4967800a4e255
https://doi.org/10.1021/jacs.2c02146
https://doi.org/10.1021/jacs.2c02146
Autor:
Carolyn J. Straub, Lisa E. Rusali, Andrew P. Riley, Bernard D. Santarsiero, Malaika D. Argade
Publikováno v:
Organic Letters. 23:7693-7697
The first synthesis of aristoquinoline (1), a naturally occurring nicotinic acetylcholine receptor (nAChR) antagonist, was accomplished using two different approaches. Comparison of the synthetic material's spectroscopic data to that of the isolated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632d61cbed6e8c189e3094f641fac4c1
https://doi.org/10.1021/acs.orglett.1c02057
https://doi.org/10.1021/acs.orglett.1c02057
Autor:
Andy I Nguyen, Zhong Ren, Bernard D Santarsiero, Dan McElheny, Sabari Ghosh, Phuong Nguyen Tran, Viet Thuc Dang, Sherrie L Heinz-Kunert, Ashma Pandya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35ceb1ff5e6eafb3a2c028f6cbc00e8
https://doi.org/10.1021/scimeetings.2c00504
https://doi.org/10.1021/scimeetings.2c00504
Autor:
Michael W. Mullowney, Eoghainín Ó hAinmhire, Anam Shaikh, Xiaomei Wei, Urszula Tanouye, Bernard D. Santarsiero, Joanna E. Burdette, Brian T. Murphy
Publikováno v:
Marine Drugs, Vol 12, Iss 6, Pp 3574-3586 (2014)
As part of our program to identify novel secondary metabolites that target drug-resistant ovarian cancers, a screening of our aquatic-derived actinomycete fraction library against a cisplatin-resistant ovarian cancer cell line (OVCAR5) led to the iso
Externí odkaz:
https://doaj.org/article/031ec5d1d22b43b5bfc305232882e246
Autor:
Brian T. Murphy, John M. Pezzuto, Sang-Jip Nam, Bernard D. Santarsiero, Laura Marler, Skylar Carlson
Publikováno v:
Marine Drugs, Vol 11, Iss 4, Pp 1152-1161 (2013)
Agents capable of inducing phase II enzymes such as quinone reductase 1 (QR1) are known to have the potential of mediating cancer chemopreventive activity. As part of a program to discover novel phase II enzyme-inducing molecules, we identified a mar
Externí odkaz:
https://doaj.org/article/172e89e421e343ca80741f5c61993b3e
Autor:
James B. McAlpine, Guido F. Pauli, Shao-Nong Chen, Hyun Lee, Joo-Won Suh, Cele Abad-Zapatero, Nina M. Wolf, Sang-Hyun Cho, Bin Zhou, Scott G. Franzblau, Gauri Shetye, Jonathan Bisson, Hanki Lee, Yang Yu, Jinhua Cheng, Larry L. Klein, Ying-Yu Jin, Bernard D. Santarsiero
Publikováno v:
J Nat Prod
This study represents a systematic chemical and biological study of the rufomycin (RUF) class of cyclic heptapeptides, which our anti-TB drug discovery efforts have identified as potentially promising anti-TB agents that newly target the caseinolytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd9a3473d6c6b013e25e1c673634883d
https://doi.org/10.1021/acs.jnatprod.9b01095
https://doi.org/10.1021/acs.jnatprod.9b01095
Autor:
Hyun Lee, Shahila Mehboob, Kirk E. Hevener, Bernard D. Santarsiero, Jesse A. Jones, Teuta Boci, Michael E. Johnson
Enoyl-acyl carrier protein (ACP) reductase II (FabK) is a critical rate-limiting enzyme in the bacterial type II fatty-acid synthesis (FAS II) pathway. FAS II pathway enzymes are markedly disparate from their mammalian analogs in the FAS I pathway in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8adfbfbdb3246761b0b94600938d0a9b
Autor:
M. Galbusera, D. Santarsiero, S. Gastoldi, A. Schubart, M. Vivarelli, E. Bresin, A. Benigni, M. Noris, G. Remuzzi
Publikováno v:
Kidney International Reports. 7:S453-S454
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a69a8ec14ca57e840ac1c081fee7dfdf
https://doi.org/10.1016/j.ekir.2022.04.059
https://doi.org/10.1016/j.ekir.2022.04.059